Market Momentum Report: BioCardia Inc. (BCDA)’s Negative Close at 2.54

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of BioCardia Inc. (NASDAQ: BCDA) closed at $2.54 in the last session, down -14.77% from day before closing price of $2.98. In other words, the price has decreased by -$14.77 from its previous closing price. On the day, 0.54 million shares were traded. BCDA stock price reached its highest trading level at $2.95 during the session, while it also had its lowest trading level at $2.5.

Ratios:

We take a closer look at BCDA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.39 and its Current Ratio is at 0.39.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 01 ’24 when Altman Peter bought 300 shares for $3.05 per share. The transaction valued at 915 led to the insider holds 39,745 shares of the business.

Altman Peter bought 200 shares of BCDA for $598 on Jun 28 ’24. The President and CEO now owns 39,445 shares after completing the transaction at $2.99 per share. On Jun 21 ’24, another insider, Altman Peter, who serves as the President and CEO of the company, bought 500 shares for $3.29 each. As a result, the insider paid 1,645 and bolstered with 39,245 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCDA now has a Market Capitalization of 8894750 and an Enterprise Value of 5111645. For the stock, the TTM Price-to-Sale (P/S) ratio is 20.67. Its current Enterprise Value per Revenue stands at 11.943 whereas that against EBITDA is -0.599.

Stock Price History:

Over the past 52 weeks, BCDA has reached a high of $23.25, while it has fallen to a 52-week low of $1.96. The 50-Day Moving Average of the stock is -12.11%, while the 200-Day Moving Average is calculated to be -53.75%.

Shares Statistics:

According to the various share statistics, BCDA traded on average about 827.79K shares per day over the past 3-months and 327540 shares per day over the past 10 days. A total of 3.50M shares are outstanding, with a floating share count of 2.36M. Insiders hold about 32.62% of the company’s shares, while institutions hold 2.47% stake in the company. Shares short for BCDA as of 1724976000 were 1829037 with a Short Ratio of 2.21, compared to 1722384000 on 31787. Therefore, it implies a Short% of Shares Outstanding of 1829037 and a Short% of Float of 97.540003.

Most Popular